Three companies recently announced progression in their clinical research for next-generation Covid-19 vaccines: INOVIO, ...

Monoclonal antibodies are essential for biomedical ... while eliminating many of the challenges associated with their production," explains Nicolas Winssinger. More specifically, SAPs consist ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

The global antibody market is poised for remarkable expansion over the next decade, with market estimates predicting a significant rise in valuation from USD 266.83 billion in 2024 to an impressive ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

This eBook explores how innovative medium and feed systems can support the successful scale-up of mAb processes, while maintaining productivity and cost-efficiency, supporting faster speed-to-market.

Traditional monoclonal antibody production faces seasonality and distribution constraints. By contrast, INOVIO’s DMAb ...

In the landmark Amgen v. Sanofi case (previously covered here), the Supreme Court affirmed that patent claims drawn to a genus of ...

"These findings could represent a breakthrough as they demonstrate the potential of DMAb technology to overcome traditional monoclonal antibody production challenges, such as short half-life and ...

Bengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the U.S. Food and Drug Administration (U.S. FDA) has approved Jobevne (bevacizumab-nwgd), a ...

The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who ...